• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肝病住院儿童肝性脑病的患病率及诱发因素

Prevalence and Precipitants of Hepatic Encephalopathy in Hospitalized Children With Chronic Liver Disease.

作者信息

Ravindranath Aathira, Srivastava Anshu, Yachha Surender K, Poddar Ujjal, Sarma Moinak S, Mathias Amrita

机构信息

Department of Pediatric Gastroenterology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.

出版信息

J Clin Exp Hepatol. 2024 Nov-Dec;14(6):101452. doi: 10.1016/j.jceh.2024.101452. Epub 2024 May 31.

DOI:10.1016/j.jceh.2024.101452
PMID:39005950
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11245966/
Abstract

OBJECTIVE

Hepatic encephalopathy (HE) is a marker of poor prognosis in adults with chronic liver disease (CLD). We prospectively studied the prevalence and precipitants of HE in children with CLD as there is a paucity of literature on the same.

METHODS

Children (1-18 years) admitted with CLD were examined daily for the presence and grading of HE (West Haven/Whittington grading). Precipitants were classified as infection, dyselectrolytemia, gastrointestinal bleeding, constipation and dehydration. Changes in grades of HE and outcome were noted.

RESULTS

One hundred and sixty children (age 120 [84-168] months) were enrolled. HE was present in 50 (31.2%) patients with a total of 61 episodes. Maximum grade of HE was grade I (n = 16), II (n = 23), III (n = 11) and IV (n = 11). Forty-two cases had single and 8 had recurrent (2-5) episodes. Median duration of HE episodes was 96 (72-192) hours. Precipitants were identified in 55/61 (90.2%) episodes with infection (45/61, 73.7%) and dyselectrolytemia (33/61, 54%) being the most common. Lower albumin and sodium, higher INR and presence of infection were significantly associated with presence of HE. Overall, HE resolved in 33 (54%) episodes, while it progressed and persisted in 28 (45.9%) episodes. Patients with HE had a poorer outcome (25/50 vs 13/110;  < 0.01) with both higher in-hospital (11/50 vs 9/110;  = 0.02) and 1-month post discharge (14/39 vs 4/101; < 0.01) mortality than those without HE.

CONCLUSION

One-third of admitted CLD children have HE, with identifiable precipitants in 90% of cases. Children with HE have poorer liver functions, higher rate of infections and worse outcome than those without HE.

摘要

目的

肝性脑病(HE)是成人慢性肝病(CLD)预后不良的一个指标。由于关于儿童CLD中HE的文献较少,我们对其患病率和诱因进行了前瞻性研究。

方法

对收治的1-18岁CLD患儿每天检查是否存在HE及其分级(韦斯特黑文/惠廷顿分级)。诱因分为感染、电解质紊乱、胃肠道出血、便秘和脱水。记录HE分级变化及转归情况。

结果

共纳入160例儿童(年龄120[84-168]个月)。50例(31.2%)患者存在HE,共61次发作。HE最高分级为I级(n = 16)、II级(n = 23)、III级(n = 11)和IV级(n = 11)。42例为单次发作,8例有复发(2-5次)发作。HE发作的中位持续时间为96(72-192)小时。55/61(90.2%)次发作中发现了诱因,其中感染(45/61,73.7%)和电解质紊乱(33/61,54%)最为常见。较低的白蛋白和钠水平、较高的国际标准化比值(INR)以及感染的存在与HE的发生显著相关。总体而言,33次(54%)发作中HE得到缓解,而28次(45.9%)发作中HE进展并持续。与无HE的患者相比,HE患者的预后较差(25/50对13/110;P<0.01),住院死亡率(11/50对9/110;P = 0.02)和出院后1个月死亡率(14/39对4/101;P<0.01)均更高。

结论

三分之一的住院CLD儿童患有HE,90%的病例有可识别的诱因。与无HE的儿童相比,HE儿童的肝功能较差、感染率较高且预后较差。

相似文献

1
Prevalence and Precipitants of Hepatic Encephalopathy in Hospitalized Children With Chronic Liver Disease.慢性肝病住院儿童肝性脑病的患病率及诱发因素
J Clin Exp Hepatol. 2024 Nov-Dec;14(6):101452. doi: 10.1016/j.jceh.2024.101452. Epub 2024 May 31.
2
Nutritional support for liver disease.肝病的营养支持
Cochrane Database Syst Rev. 2012 May 16;2012(5):CD008344. doi: 10.1002/14651858.CD008344.pub2.
3
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
4
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
5
Global prevalence and characteristics of infections and clinical outcomes in hospitalised patients with cirrhosis: a prospective cohort study for the CLEARED Consortium.全球肝硬化住院患者感染的流行情况和特征及临床结局:CLEARED 联盟的一项前瞻性队列研究。
Lancet Gastroenterol Hepatol. 2024 Nov;9(11):997-1009. doi: 10.1016/S2468-1253(24)00224-3. Epub 2024 Sep 5.
6
Prognosis of adults and children following a first unprovoked seizure.首次无诱因发作后成人和儿童的预后。
Cochrane Database Syst Rev. 2023 Jan 23;1(1):CD013847. doi: 10.1002/14651858.CD013847.pub2.
7
The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.卡莫司汀植入剂与替莫唑胺治疗新诊断的高级别胶质瘤的有效性和成本效益:一项系统评价与经济学评估
Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. doi: 10.3310/hta11450.
8
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
9
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
10
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.

本文引用的文献

1
EASL Clinical Practice Guidelines on the management of hepatic encephalopathy.EASL 临床实践指南:肝性脑病管理。
J Hepatol. 2022 Sep;77(3):807-824. doi: 10.1016/j.jhep.2022.06.001. Epub 2022 Jun 17.
2
Cirrhosis-associated immune dysfunction.肝硬化相关免疫功能障碍。
Nat Rev Gastroenterol Hepatol. 2022 Feb;19(2):112-134. doi: 10.1038/s41575-021-00520-7. Epub 2021 Oct 26.
3
Efficacy and Safety of Sodium Benzoate in The Management of Hyperammonemia in Decompensated Chronic Liver Disease of the Childhood-A Double-blind Randomized Controlled Trial.苯甲酸钠治疗儿童失代偿期慢性肝病高氨血症的疗效和安全性:一项双盲随机对照试验。
J Pediatr Gastroenterol Nutr. 2020 Feb;70(2):165-170. doi: 10.1097/MPG.0000000000002521.
4
Clinical characteristics of patients with liver cirrhosis and spontaneous portosystemic shunts detected by ultrasound in a tertiary care and transplantation centre.在一家三级医疗和移植中心通过超声检测出的肝硬化合并自发性门体分流患者的临床特征
Scand J Gastroenterol. 2018 Sep;53(9):1107-1113. doi: 10.1080/00365521.2018.1498913. Epub 2018 Sep 29.
5
Prevalence and Impact of Bacterial Infections in Children With Liver Disease-A Prospective Study.肝病患儿细菌感染的患病率及影响——一项前瞻性研究
J Clin Exp Hepatol. 2018 Mar;8(1):35-41. doi: 10.1016/j.jceh.2017.08.007. Epub 2017 Sep 14.
6
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis.欧洲肝脏研究学会失代偿期肝硬化患者管理临床实践指南
J Hepatol. 2018 Aug;69(2):406-460. doi: 10.1016/j.jhep.2018.03.024. Epub 2018 Apr 10.
7
A risk score to predict the development of hepatic encephalopathy in a population-based cohort of patients with cirrhosis.一种用于预测肝硬化患者人群中肝性脑病发展的风险评分。
Hepatology. 2018 Oct;68(4):1498-1507. doi: 10.1002/hep.29628. Epub 2018 May 14.
8
Pediatric CLIF-SOFA score is the best predictor of 28-day mortality in children with decompensated chronic liver disease.儿科 CLIF-SOFA 评分是预测失代偿性慢性肝病儿童 28 天死亡率的最佳指标。
J Hepatol. 2018 Mar;68(3):449-455. doi: 10.1016/j.jhep.2017.10.001. Epub 2017 Oct 10.
9
Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis.慢性加急性肝衰竭患者的细菌和真菌感染:流行率、特征及对预后的影响。
Gut. 2018 Oct;67(10):1870-1880. doi: 10.1136/gutjnl-2017-314240. Epub 2017 Aug 28.
10
A New Look at Precipitants of Overt Hepatic Encephalopathy in Cirrhosis.肝硬化中显性肝性脑病诱因的新视角
Dig Dis Sci. 2017 Aug;62(8):2166-2173. doi: 10.1007/s10620-017-4630-y. Epub 2017 May 30.